Vnitr Lek 2016, 62(1):48-51

Rare diagnostics of infective endocarditis after kidney transplantation

Ivana Dedinská1,*, Petra Skalová1, Michal Mokáň2, Katarína Martiaková2, Denisa Osinová3, Miroslav Pindura1, Blažej Palkoci1, Marián Vojtko4, Janka Hubová4, Denisa Kadlecová4, Ivona Lendová4, Radovan Zacharovský5, Filip Pekar5, Lucia Kaliská6
1 Chirurgická klinika a transplantačné centrum JLF UK a UN Martin, Slovenská republika
2 I. interná klinika JLF UK a UN Martin, Slovenská republika
3 Klinika anestéziológie a intenzívnej medicíny JLF UK a UN Martin, Slovenská republika
4 Dialyzačné stredisko B. Braun Avitum, s.r.o., Trstená, Slovenská republika
5 Stredoslovenský ústav srdcových a cievnych chorôb, a.s., Banská Bystrica, Slovenská republika
6 Agel diagnostic, a.s., Banská Bystrica, Slovenská republika

Introduction:
Infective endocarditis in a patient after kidney transplantation is a serious infective complication which increases the risk of loss of the graft and also the mortality of patients. The most important predisposing factor is the immunosuppressive therapy - mainly induction immunosuppression.


Material and case description:
250 patients underwent kidney transplantation throughout the period of 12 years in the Transplant Center Martin. This set of patients included 5 patients (2 %) after heart valve replacement. We present the case of a patient after kidney transplantation with development of endocarditis of the bioprosthesis of the aortic valve one month after successful kidney transplantation. Diagnostics of endocarditis by standard procedures (examination by transthoracic echocardiogram, transesophageal echocardiography, hemocultures) was unsuccessful. We rarely diagnosed endocarditis only by PET-CT examination with a consequent change of the antibiotic treatment and successful managing of this post-transplant complication.

Conclusion:
Endocarditis after kidney transplantation is a serious complication which significantly worsens the mortality of patients. The risk of development of infective endocarditis after transplantation is also increased by induction, mainly by antithymocyte globulin. Diagnostics only by PET-CT examination is rare; however, in this case it fundamentally changed the approach to the patient and led to a successful treatment.

Keywords: endocarditis; induction; kidney transplantation; PET-CT

Received: July 22, 2015; Accepted: September 7, 2015; Published: January 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dedinská I, Skalová P, Mokáň M, Martiaková K, Osinová D, Pindura M, et al.. Rare diagnostics of infective endocarditis after kidney transplantation. Vnitr Lek. 2016;62(1):48-51.
Download citation

References

  1. Miklušica J, Grandtnerová B, Grendár J et al. Príčiny neidentifikovania darcu orgánov. Orgánové transplantácie 2005; 1(2): 8-9.
  2. Dedinská I, Galajda, P, Laca Ľ et al. Imunosupresia a novovzniknutý diabetes mellitus po transplantácii obličky. P + M: Turany 2014. ISBN 9788089694082.
  3. Grandtnerová B, Laca Ľ, Gábor D et al. Folic acid supplementation and homocyst(e)ine level in renal transplant recipients. Transplant Proc 2001; 33(1-2): 2049-2050. Go to original source... Go to PubMed...
  4. Viklický O, Janoušek L, Baláž P. Transplantace ledviny v klinické praxi. Grada: Praha 2008: 223-224. ISBN 978-80-247-2455-3.
  5. Žilinská Z, Chrastina M, Trebatický B et al. Vascular complications after renal transplantation. Bratisl Lek Listy 2010; 111(11): 586-589. Go to PubMed...
  6. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1-S155.
  7. Einollahi B, Lessan-Pezeshki M, Pourfarziani V et al. Does CMV infection increase the incidence of infective endocarditis following kidney transplantation? Ann Transplant 2009; 14(1): 32-37. Go to PubMed...
  8. Martin-Davila P, Fortun J, Navas E et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005; 128(2): 772-779. Go to original source... Go to PubMed...
  9. Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am 2002; 16(2): 273-295, vii-viii. Go to original source... Go to PubMed...
  10. Shroff GR, Skeans M, Herzog CA. Outcomes of renal transplant and waiting list patients with bacterial endocarditis in the United States. Nephrol Dial Transplant 2008; 23(7): 2381-2385. Go to original source... Go to PubMed...
  11. Horstkotte D, Follath F, Gutschik E et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis. The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25(3): 267-276. Go to original source... Go to PubMed...
  12. Issa NC, Fishman JA. Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation. Clin Infect Dis 2009; 48(6): 772-786. Go to original source... Go to PubMed...
  13. Moshkani Farahani M, Rostami Z, Einollahi B et al. Infective Endocarditis After Renal Transplantation. Nephrourol Mon 2014; 6 (1):e12326. Dostupné z DOI: <http://dx.doi.org/10.5812/numonthly.12326>. Go to original source... Go to PubMed...
  14. Graziosi M, Nanni C, Lorenzini M et al. Role of 18F - FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging 2014; 41(8): 1617-1623. Go to original source... Go to PubMed...
  15. Saby L, Laas O, Habib G et al. Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis: Increased Valvular 18F-Fluorodeoxyglucose Uptake as a Novel Major Criterion. J Am Coll Cardiol 2013; 61(23): 2374-2382. Go to original source... Go to PubMed...
  16. Sabol F, Jakubová M, Kolesár A et al. Recidivujúca protetická endokarditída u 21-ročného pacienta s transplantovanou obličkou riešená alogénnym homograftom. Vnitř Lék 2012; 58(6): 494-498. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.